A citation-based method for searching scientific literature

Bayan Alzumaili, Bin Xu, Philip M Spanheimer, R Michael Tuttle, Eric Sherman, Nora Katabi, Snjezana Dogan, Ian Ganly, Brian R Untch, Ronald A Ghossein. Mod Pathol 2020
Times Cited: 15







List of co-cited articles
56 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis.
Talia L Fuchs, Anthony J Nassour, Anthony Glover, Mark S Sywak, Stan B Sidhu, Leigh W Delbridge, Roderick J Clifton-Bligh, Matti L Gild, Venessa Tsang, Bruce G Robinson,[...]. Am J Surg Pathol 2020
17
60

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
960
46

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
Rossella Elisei, Barbara Cosci, Cristina Romei, Valeria Bottici, Giulia Renzini, Eleonora Molinaro, Laura Agate, Agnese Vivaldi, Pinuccia Faviana, Fulvio Basolo,[...]. J Clin Endocrinol Metab 2008
324
33

Evaluation of grade in a genotyped cohort of sporadic medullary thyroid carcinomas.
Fedaa Najdawi, Sara Ahmadi, Marzia Capelletti, Fei Dong, Nicole G Chau, Justine A Barletta. Histopathology 2021
6
83

International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma.
Bin Xu, Talia L Fuchs, Sara Ahmadi, Mohammed Alghamdi, Bayan Alzumaili, Mohamed-Amine Bani, Eric Baudin, Angela Chou, Antonio De Leo, James A Fagin,[...]. J Clin Oncol 2022
13
38

Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification.
Caterina Mian, Gianmaria Pennelli, Susi Barollo, Elisabetta Cavedon, Davide Nacamulli, Federica Vianello, Isabella Negro, Giulia Pozza, Isabella Merante Boschin, Maria Rosa Pelizzo,[...]. Eur J Endocrinol 2011
64
26

Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study.
Michael Rivera, Julio Ricarte-Filho, Snehal Patel, Michael Tuttle, Ashok Shaha, Jatin P Shah, James A Fagin, Ronald A Ghossein. Hum Pathol 2010
45
20


Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine.
E Modigliani, R Cohen, J M Campos, B Conte-Devolx, B Maes, A Boneu, M Schlumberger, J C Bigorgne, P Dumontier, L Leclerc,[...]. Clin Endocrinol (Oxf) 1998
356
20

Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity.
J B HAZARD, W A HAWK, G CRILE. J Clin Endocrinol Metab 1959
699
20


High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas.
Michele Simbolo, Caterina Mian, Susi Barollo, Matteo Fassan, Andrea Mafficini, Diogo Neves, Maria Scardoni, Gianmaria Pennelli, Massimo Rugge, Maria Rosa Pelizzo,[...]. Virchows Arch 2014
57
20

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing.
Raffaele Ciampi, Cristina Romei, Teresa Ramone, Alessandro Prete, Alessia Tacito, Virginia Cappagli, Valeria Bottici, David Viola, Liborio Torregrossa, Clara Ugolini,[...]. iScience 2019
55
20

The Ki67 index a prognostic marker in medullary thyroid carcinoma.
L E Tisell, A Oden, A Muth, G Altiparmak, J Mõlne, H Ahlman, O Nilsson. Br J Cancer 2003
50
20




Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach.
Marco Volante, Paola Collini, Yuri E Nikiforov, Atsuhiko Sakamoto, Kennichi Kakudo, Ryohei Katoh, Ricardo V Lloyd, Virginia A LiVolsi, Mauro Papotti, Manuel Sobrinho-Simoes,[...]. Am J Surg Pathol 2007
337
13

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.
Yuri E Nikiforov, Raja R Seethala, Giovanni Tallini, Zubair W Baloch, Fulvio Basolo, Lester D R Thompson, Justine A Barletta, Bruce M Wenig, Abir Al Ghuzlan, Kennichi Kakudo,[...]. JAMA Oncol 2016
820
13

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
13

Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
David Hiltzik, Diane L Carlson, R Michael Tuttle, Shaokun Chuai, Nicole Ishill, Ashok Shaha, Jatin P Shah, Buvanesh Singh, Ronald A Ghossein. Cancer 2006
190
13

Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Michael Rivera, Ronald A Ghossein, Heiko Schoder, Daniel Gomez, Steven M Larson, R Michael Tuttle. Cancer 2008
128
13

Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).
Michael Rivera, R Michael Tuttle, Snehal Patel, Ashok Shaha, Jatin P Shah, Ronald A Ghossein. Thyroid 2009
90
13

The History of the Follicular Variant of Papillary Thyroid Carcinoma.
Giovanni Tallini, R Michael Tuttle, Ronald A Ghossein. J Clin Endocrinol Metab 2017
67
13


Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.
Kristine S Wong, Jochen H Lorch, Erik K Alexander, Ellen Marqusee, Nancy L Cho, Matthew A Nehs, Gerard M Doherty, Justine A Barletta. Thyroid 2019
13
15

Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.
Bin Xu, Talia Fuchs, Snjezana Dogan, Iñigo Landa, Nora Katabi, James A Fagin, R Michael Tuttle, Eric Sherman, Anthony J Gill, Ronald Ghossein. Thyroid 2020
58
13

Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer.
Allen S Ho, Lu Wang, Frank L Palmer, Changhong Yu, Arnbjorn Toset, Snehal Patel, Michael W Kattan, R Michael Tuttle, Ian Ganly. Ann Surg Oncol 2015
28
13

PAX8-GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid.
Caterina Marchiò, Arnaud Da Cruz Paula, Rodrigo Gularte-Merida, Thais Basili, Alissa Brandes, Edaise M da Silva, Catarina Silveira, Lorenzo Ferrando, Jasna Metovic, Francesca Maletta,[...]. Mod Pathol 2019
20
13

GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland.
Marina N Nikiforova, Alyaksandr V Nikitski, Federica Panebianco, Cihan Kaya, Linwah Yip, Michelle Williams, Simion I Chiosea, Raja R Seethala, Somak Roy, Vincenzo Condello,[...]. Thyroid 2019
33
13

RET/PTC activation in hyalinizing trabecular tumors of the thyroid.
M Papotti, M Volante, A Giuliano, A Fassina, A Fusco, G Bussolati, M Santoro, G Chiappetta. Am J Surg Pathol 2000
89
13

Hyalinizing trabecular tumors of the thyroid gland are almost all benign.
J Aidan Carney, Mitsuyoshi Hirokawa, Ricardo V Lloyd, Mauro Papotti, Thomas J Sebo. Am J Surg Pathol 2008
51
13

Hyalinizing trabecular carcinoma of thyroid gland.
W G McCluggage, J M Sloan. Histopathology 1996
45
13

Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
Eric J Kuo, Shonan Sho, Ning Li, Kyle A Zanocco, Michael W Yeh, Masha J Livhits. JAMA Surg 2018
35
13

High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas.
Margarida M Moura, Branca M Cavaco, António E Pinto, Valeriano Leite. J Clin Endocrinol Metab 2011
153
13

Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.
Nishant Agrawal, Yuchen Jiao, Mark Sausen, Rebecca Leary, Chetan Bettegowda, Nicholas J Roberts, Sheetal Bhan, Allen S Ho, Zubair Khan, Justin Bishop,[...]. J Clin Endocrinol Metab 2013
144
13

Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma.
Elizabeth G Grubbs, Michelle D Williams, Paul Scheet, Selina Vattathil, Nancy D Perrier, Jeffrey E Lee, Robert F Gagel, Tao Hai, Lei Feng, Maria E Cabanillas,[...]. Thyroid 2016
25
13

Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas.
M M Moura, B M Cavaco, A E Pinto, R Domingues, J R Santos, M O Cid, M J Bugalho, V Leite. Br J Cancer 2009
102
13

Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
Lori J Wirth, Eric Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen Lorch, Francis Worden, Marcia Brose, Jyoti Patel, Sophie Leboulleux,[...]. N Engl J Med 2020
192
13

Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
673
13

Comprehensive Immune Profiling of Medullary Thyroid Cancer.
Nikita Pozdeyev, Timothy A Erickson, Lian Zhang, Kim Ellison, Christopher J Rivard, Sharon Sams, Fred R Hirsch, Bryan R Haugen, Jena D French. Thyroid 2020
16
13

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli,[...]. J Clin Oncol 2012
865
13


Response to initial therapy predicts clinical outcomes in medullary thyroid cancer.
Susan C Lindsey, Ian Ganly, Frank Palmer, R Michael Tuttle. Thyroid 2015
40
13

Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
Sena Turkdogan, Véronique-Isabelle Forest, Michael P Hier, Michael Tamilia, Anca Florea, Richard J Payne. J Otolaryngol Head Neck Surg 2018
17
13

Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study.
Else Marie Opsahl, Lars Andreas Akslen, Ellen Schlichting, Turid Aas, Katrin Brauckhoff, Anne Irene Hagen, Alf Frimann Rosenlund, Eva Sigstad, Krystyna K Grøholt, Lovise Mæhle,[...]. Eur Thyroid J 2019
11
18

Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Andreas Machens, Kerstin Lorenz, Frank Weber, Henning Dralle. J Clin Endocrinol Metab 2021
7
28

Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
Anupam Kotwal, Dana Erickson, Jennifer R Geske, Ian D Hay, M Regina Castro. Thyroid 2021
12
16

Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.
Carlotta Giani, Liborio Torregrossa, Teresa Ramone, Cristina Romei, Antonio Matrone, Eleonora Molinaro, Laura Agate, Gabriele Materazzi, Paolo Piaggi, Clara Ugolini,[...]. J Clin Endocrinol Metab 2021
4
50

Correlation of molecular data with histopathological and clinical features in a series of 66 patients with medullary thyroid carcinoma.
M M Moura, R A Cabrera, S Esteves, B M Cavaco, P Soares, V Leite. J Endocrinol Invest 2021
2
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.